How Estrogen Exposure and Hormone Therapy Impact Women’s Brain Health and Vascular Aging

Longer estrogen exposure tied to fewer brain blood vessel problems at age 70

Hormonal history across a woman’s lifespan leaves a measurable mark on the brain’s cerebrovascular health decades later, according to new research published in the journal Neurology and covered by The Washington Post.

The study tracked data from 352 healthy Swedish women born in 1944 who are part of the Gothenburg H70 Birth Cohort Studies. Researchers found that women with longer reproductive periods, as well as those who used hormone replacement therapy during menopause, tended to exhibit fewer signs of small vessel disease in their brains by the time they reached age 70.

Small vessel disease risk drops with extended hormone exposure

For every additional year a woman’s reproductive lifespan lasted, her odds of showing two or more signs of small vessel disease at age 70 decreased by roughly 8 percent. Scientists point to later menopause rather than an earlier age of first menstruation as the primary driver behind this statistical association.

Neurobiologist Anna Marseglia of the Karolinska Institutet in Sweden notes that hormonal exposure across different life stages yields cumulative effects on cerebrovascular health in late life. The findings suggest that the brain’s cerebrovascular network may serve as a crucial mediator in the link between estrogen and brain aging.

Hormone therapy preserves brain white matter integrity

Participants in the cohort underwent magnetic resonance imaging brain scans at age 70, with a majority returning for a follow-up assessment at age 75. Beyond reductions in small vessel disease markers, women who used menopausal hormone therapies also displayed better microstructural integrity in their brain’s white matter.

The analysis revealed a distinct interaction among carriers of the APOE-ε4 gene variant, a known genetic risk factor for Alzheimer’s disease. Among women carrying this specific gene, hormone therapy use correlated with greater cortical thickness in brain regions typically vulnerable to Alzheimer’s pathology. Conversely, the study found no such association among women lacking the APOE-ε4 variant.

Researchers use elastography to detect hormone shifts

While the Swedish cohort study relies on historical health data and late-life imaging, other research teams are actively investigating how these physiological shifts impact brain function. At the University of Delaware’s Mechanical Neuroimaging Lab, director Curtis Johnson and postdoctoral researcher Katrina Milbocker utilize Magnetic Resonance Elastography to detect hormone-related alterations in a part of the brain. Operating out of the Center for Biomedical and Brain Imaging, their research examines whether these hormonal changes affect brain function.

Study authors emphasize that because the work remains observational, the findings cannot definitively establish cause and effect. Investigators note that maintaining cerebrovascular health and understanding cognitive trajectories remains a vital priority within modern personalized medicine.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.